|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Consolidated net income | |||||
| Adjustments to reconcile consolidated net income to net cash provided by operating activities | |||||
| Provision for credit losses | |||||
| Deferred tax expense (benefit) | |||||
| Depreciation and amortization of premises and equipment | |||||
| Loss on sale of fixed assets | |||||
| Net amortization of securities | |||||
| Net realized losses on sales of securities | |||||
| Gains on mortgage loans sold, net | |||||
| Share-based compensation expense | |||||
| Loss on other real estate | |||||
| Loss on sale of other assets | |||||
| Loss on sale of investment in joint venture | |||||
| Increase in value of life insurance and annuity contracts | |||||
| Mortgage loans originated for resale | |||||
| Proceeds from sale of mortgage loans | |||||
| Gain on lease modification | |||||
| Right of use asset amortization | |||||
| Amortization of premium on loans | |||||
| Amortization of core deposit intangibles | |||||
| Accretion of premium on time deposits | |||||
| Amortization of mortgage servicing rights | |||||
| Change in | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued interest payable | |||||
| Other liabilities | |||||
| TOTAL ADJUSTMENTS | |||||
| NET CASH PROVIDED BY OPERATING ACTIVITIES | |||||
| INVESTING ACTIVITIES | |||||
| Purchases | |||||
| Sales | |||||
| Maturities, prepayments and calls | |||||
| Redemptions (purchases) of restricted equity securities | |||||
| Net increase in loans | |||||
| Purchase of buildings, leasehold improvements, and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from Sale of Other Real Estate | |||||
| Proceeds from sale of other assets | |||||
| Purchase of life insurance and annuity contracts | |||||
| Redemption of annuity contracts | |||||
| Increase in other investments | |||||
| Decrease in cash from sale of joint venture | |||||
| Cash received from acquisition, net | |||||
| NET CASH USED IN INVESTING ACTIVITIES | |||||
| FINANCING ACTIVITIES | |||||
| Net change in deposits - non-maturing | |||||
| Net change in deposits - time | |||||
| Net change in Federal Home Loan Bank Advances | |||||
| Change in escrow balances | |||||
| Repayment of finance lease obligation | |||||
| Noncontrolling interest contributions | |||||
| Issuance of common stock related to exercise of stock options | |||||
| Issuance of common stock pursuant to dividend reinvestment plan | |||||
| Forfeiture of performance stock units | |||||
| Forfeiture of restricted stock units | |||||
| Repurchase of common stock | |||||
| Cash dividends paid on common stock | |||||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | |||||
| NET CHANGE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS - END OF YEAR | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest | |||||
| Federal | |||||
| State | |||||
| Total | |||||
| Non-cash investing and financing activities: | |||||
| Change in fair value of securities available-for-sale, net of taxes of $(11,698) in 2025, $22 in 2024, and $(7,878) in 2023 | |||||
| Non-cash transfers from loans to other real estate | |||||
| Non-cash transfers from other real estate to loans | |||||
| Non-cash transfers from loans to other assets | |||||
| Cash and cash equivalents summary: | |||||
| Interest bearing deposits | |||||
| Federal funds sold | |||||
| Cash and due from banks | |||||
| Cash and cash equivalents - end of period | |||||
Loading...